Research Institute of the McGill University Health Centre (Campbell, Oxlade, Fregonese, Menzies, Oh, Bastos, Sulis); Faculty of Medicine (Campbell, Menzies, Winters, Sulis, Uppal, Yanes-Lane, Lan), McGill University; McGill International TB Centre (Campbell, Oxlade, Fregonese, Menzies, Bastos, Sulis, Law); Department of Economics (Laszlo) and School of Population and Global Health (Evans), McGill University, Montréal, Que.; Department of Management Science and Engineering (Russell), Stanford University, Stanford, Calif.; Department of Pediatrics (Oh), Kosin University College of Medicine, Busan, Republic of Korea; Department of Epidemiology (Bastos), Social Medicine Institute, State University of Rio de Janeiro, Rio de Janeiro, Brazil; Department of Global Health and Social Medicine (Law), Harvard Medical School, Boston, Mass.; Département de médicine social et preventive (Brisson), Université Laval, Québec, Que.
CMAJ. 2020 Oct 5;192(40):E1146-E1155. doi: 10.1503/cmaj.201128. Epub 2020 Sep 9.
Testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely passive, which impedes epidemic control. We defined active testing strategies for SARS-CoV-2 using reverse transcription polymerase chain reaction (RT-PCR) for groups at increased risk of acquiring SARS-CoV-2 in all Canadian provinces.
We identified 5 groups who should be prioritized for active RT-PCR testing: contacts of people who are positive for SARS-CoV-2, and 4 at-risk populations - hospital employees, community health care workers and people in long-term care facilities, essential business employees, and schoolchildren and staff. We estimated costs, human resources and laboratory capacity required to test people in each group or to perform surveillance testing in random samples.
During July 8-17, 2020, across all provinces in Canada, an average of 41 751 RT-PCR tests were performed daily; we estimated this required 5122 personnel and cost $2.4 million per day ($67.8 million per month). Systematic contact tracing and testing would increase personnel needs 1.2-fold and monthly costs to $78.9 million. Conducted over a month, testing all hospital employees would require 1823 additional personnel, costing $29.0 million; testing all community health care workers and persons in long-term care facilities would require 11 074 additional personnel and cost $124.8 million; and testing all essential employees would cost $321.7 million, requiring 25 965 added personnel. Testing the larger population within schools over 6 weeks would require 46 368 added personnel and cost $816.0 million. Interventions addressing inefficiencies, including saliva-based sampling and pooling samples, could reduce costs by 40% and personnel by 20%. Surveillance testing in population samples other than contacts would cost 5% of the cost of a universal approach to testing at-risk populations.
Active testing of groups at increased risk of acquiring SARS-CoV-2 appears feasible and would support the safe reopening of the economy and schools more broadly. This strategy also appears affordable compared with the $169.2 billion committed by the federal government as a response to the pandemic as of June 2020.
目前,对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的检测主要是被动的,这阻碍了疫情的控制。我们在加拿大所有省份确定了针对 SARS-CoV-2 高风险人群的主动 RT-PCR 检测策略。
我们确定了 5 个应优先进行主动 RT-PCR 检测的群体:SARS-CoV-2 阳性者的接触者,以及 4 个高危人群——医院员工、社区卫生保健工作者和长期护理设施中的人员、基本业务员工以及学童和教职员工。我们估算了每个群体的检测成本、所需人力资源和实验室能力,或对随机样本进行监测检测的成本。
2020 年 7 月 8 日至 17 日,加拿大所有省份平均每天进行 41751 次 RT-PCR 检测;我们估计这需要 5122 名人员,每天花费 240 万美元(每月 6780 万美元)。系统接触者追踪和检测将使人员需求增加 1.2 倍,每月成本增加到 7890 万美元。在一个月内,对所有医院员工进行检测需要增加 1823 名人员,花费 2900 万美元;对所有社区卫生保健工作者和长期护理设施中的人员进行检测需要增加 11074 名人员,花费 1.248 亿美元;对所有基本员工进行检测需要花费 3.217 亿美元,需要增加 25965 名人员。在 6 周内对学校内更大的人群进行检测需要增加 46368 名人员,花费 8.16 亿美元。通过改进低效采样方式,包括唾液采样和样本混合,可以降低 40%的成本和 20%的人员需求。对接触者以外的人群样本进行监测检测的成本占高危人群普遍检测策略成本的 5%。
对感染 SARS-CoV-2 风险较高的人群进行主动检测似乎是可行的,这将有助于更广泛地安全重启经济和学校。与截至 2020 年 6 月联邦政府为应对疫情而承诺的 1692 亿美元相比,该策略似乎也具有成本效益。